Tumor Susceptibility Gene 101 (TSG101) (Middle Region) Peptide
TSG101
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits TSG101
- TSG101 (Tumor Susceptibility Gene 101 (TSG101))
- Protein Region
- Middle Region
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Séquence
- TGPPNTSYMP GMPGGISPYP SGYPPNPSGY PGCPYPPGGP YPATTSSQYP
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-TS101 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- TSG101 (Tumor Susceptibility Gene 101 (TSG101))
- Synonymes
- CG9712 Peptide, DmTSG101 Peptide, Dmel\\CG9712 Peptide, ESCRT-I Peptide, Tsg101 Peptide, burs Peptide, dTSg101 Peptide, dTsg101 Peptide, dVps23 Peptide, ept Peptide, tsg101 Peptide, vps23 Peptide, TSG101 Peptide, MGC76193 Peptide, TSG10 Peptide, VPS23 Peptide, AI255943 Peptide, CC2 Peptide, Rw Peptide, zgc:86926 Peptide, tumor susceptibility 101 Peptide, Tumor susceptibility gene 101 Peptide, Tumor Susceptibility Gene homolog Peptide, tumor susceptibility gene 101 Peptide, tumor susceptibility 101a Peptide, tumor susceptibility 101 L homeolog Peptide, TSG101 Peptide, tsg-101 Peptide, tsg101 Peptide, Tsg101 Peptide, tsg101a Peptide, tsg101.L Peptide
- Sujet
-
The protein encoded by this gene belongs to a group of apparently inactive homologs of ubiquitin-conjugating enzymes. The gene product contains a coiled-coil domain that interacts with stathmin, a cytosolic phosphoprotein implicated in tumorigenesis. The protein may play a role in cell growth and differentiation and act as a negative growth regulator. In vitro steady-state expression of this tumor susceptibility gene appears to be important for maintenance of genomic stability and cell cycle regulation. Mutations and alternative splicing in this gene occur in high frequency in breast cancer and suggest that defects occur during breast cancer tumorigenesis and/or progression.
Alias Symbols: TSG101,
Protein Size: 285 - ID gène
- 7251
-
Vous êtes ici:
